Fred Selck has more than a decade of experience as a consulting expert and testifying expert. His expertise is in applying economic and statistical analyses in IP, antitrust, regulatory, and commercial disputes in matters involving healthcare providers, insurers, pharmaceuticals, and medical devices. He has testified in U.S. District Court, U.S. Bankruptcy Court, and the Delaware Court of Chancery.
Dr. Selck’s work includes serving as a:
- Testifying expert in a foreign jurisdiction matter on behalf of a global biopharmaceutical manufacturer related to economic damages from an overturned biologic injunction.
- Testifying expert in a matter involving whether commercially reasonable efforts were performed in developing a pipeline product.
- Testifying expert in a matter alleging anticompetitive conduct by a state board in charge of regulating healthcare providers.
- Consulting expert and led the consulting team on behalf of the defendants in a class action alleging the participation of pharmacy benefit managers in the price inflation of a popular brand-name pharmaceutical product. Class certification was denied.
In addition to his role at Secretariat, Dr. Selck continues to teach graduate-level courses in health economics, innovation, and health care finance at Johns Hopkins University. His work has been published in peer-reviewed journals such as Health Services Research, Journal of Public Health Management and Practice, Statistics in Medicine, and Annals of Surgery, among others.
During his career, Dr. Selck was a partner at Bates White, where his life sciences and healthcare expertise were applied to a wide variety of matters, including patent infringement, antitrust, False Claims Act, and fraudulent conveyance claims. Previously, he was a fellow at the National Center for Health Statistics and part of the Health Economics Research Group at the Centers for Disease Control and Prevention.